Cargando…

Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium

BACKGROUND & OBJECTIVES: Increase in the isolation of drug resistant phenotypes of Mycobacterium tuberculosis necessitates accuracy in the testing methodology. Critical concentration defining resistance for ethionamide (ETO), needs re-evaluation in accordance with the current scenario. Thus, re-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakshmi, Rajagopalan, Ramachandran, Ranjani, Kumar, D. Ravi, Sundar, A. Syam, Radhika, G., Rahman, Fathima, Selvakumar, N., Kumar, Vanaja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743339/ https://www.ncbi.nlm.nih.gov/pubmed/26658587 http://dx.doi.org/10.4103/0971-5916.171278

Ejemplares similares

Consistency of standard laboratory strain Mycobacterium tuberculosis H(37)Rv with ethionamide susceptibility testing
por: Lakshmi, R., et al.
Publicado: (2012)

Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
por: Vilchèze, Catherine, et al.
Publicado: (2008)

Dilemmas with ethionamide susceptibility testing of Mycobacterium tuberculosis: A microbiologist & physician's nightmare
por: Varma-Basil, Mandira, et al.
Publicado: (2015)

Increased Susceptibility of Mycobacterium tuberculosis to Ethionamide by Expressing PPs-Induced Rv0560c
por: Seo, Hoonhee, et al.
Publicado: (2022)

EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
por: Ang, Michelle L. T., et al.
Publicado: (2017)

Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
por: Zhang, Hai-Nan, et al.
Publicado: (2017)

Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis
por: Ushtanit, Anastasia, et al.
Publicado: (2022)

Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
por: Hicks, Nathan D., et al.
Publicado: (2019)

Ethionamide-induced gynecomastia
por: Dixit, Ramakant, et al.
Publicado: (2012)

Gynecomastia caused by ethionamide
por: Sharma, Parveen K., et al.
Publicado: (2012)

Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis
por: Sarin, Rohit, et al.
Publicado: (2021)

Ectopic Expression of Rv0023 Mediates Isoniazid/Ethionamide Tolerance via Altering NADH/NAD(+) Levels in Mycobacterium smegmatis
por: Gupta, Shailesh Kumar, et al.
Publicado: (2020)

Omics analysis of Mycobacterium tuberculosis isolates uncovers Rv3094c, an ethionamide metabolism-associated gene
por: Wan, Li, et al.
Publicado: (2023)

MarR-Dependent Transcriptional Regulation of mmpSL5 Induces Ethionamide Resistance in Mycobacterium abscessus
por: Rodriguez, Ronald, et al.
Publicado: (2023)

Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China
por: Cao, Bin, et al.
Publicado: (2023)

Molecular Crystal Forms of Antitubercular Ethionamide with Dicarboxylic Acids: Solid-State Properties and a Combined Structural and Spectroscopic Study
por: Bordignon, Simone, et al.
Publicado: (2020)

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters
por: Nikiforov, Petar O., et al.
Publicado: (2016)

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
por: Nikiforov, Petar O., et al.
Publicado: (2017)

Mutation EthA(W21R) confers co-resistance to prothionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
por: Mugweru, Julius, et al.
Publicado: (2018)

Application of Cerium (IV) as an Oxidimetric Agent for the Determination of Ethionamide in Pharmaceutical Formulations
por: Basavaiah, Kanakapura, et al.
Publicado: (2016)

Ethionamide‐induced acneiform drug eruption in a patient with multiresistant tuberculosis
por: Chen, Jessica, et al.
Publicado: (2022)

Graphene oxide-based electrochemical activation of ethionamide towards enhanced biological activity
por: Mulik, Balaji B., et al.
Publicado: (2019)

Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance
por: de Welzen, Lynne, et al.
Publicado: (2017)

Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds
por: Tatum, Natalie J., et al.
Publicado: (2019)

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2017)

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
por: Pillay, Samantha, et al.
Publicado: (2022)

High Rates of Ofloxacin Resistance in Mycobacterium tuberculosis among Both New and Previously Treated Patients in Tamil Nadu, South India
por: Selvakumar, N., et al.
Publicado: (2015)

Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium
por: Dhillon, Jasvir, et al.
Publicado: (2004)

Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse
por: Palmer, Amy L., et al.
Publicado: (2012)

Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Lee, Na-Hee, et al.
Publicado: (2020)

The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
por: Song, Yanhua, et al.
Publicado: (2021)

Recent advances in anaesthesia for abdominal solid organ transplantation
por: Kumar, Lakshmi, et al.
Publicado: (2023)

Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis
por: Ranjan, K. P., et al.
Publicado: (2023)

Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation
por: Wang, Xu-De, et al.
Publicado: (2011)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2018)

Second-line antitubercular therapy with ethionamide and pyrazinamide causing pellagroid dermatitis presenting as diffuse palmoplantar keratoderma
por: Kura, Mahendra M., et al.
Publicado: (2021)

How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance
por: Maitre, Thomas, et al.
Publicado: (2022)

Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide‐induced hepatic steatosis in rats
por: Muta, Kyotaka, et al.
Publicado: (2022)

Ethionamide and Prothionamide Based Coumarinyl-Thiazole Derivatives: Synthesis, Antitubercular Activity, Toxicity Investigations and Molecular Docking Studies
por: Imran, Mohd
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0m1k9al172df3ht9k2q3sh7mos